1. bookVolumen 65 (2015): Heft 3 (September 2015)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1846-9558
Erstveröffentlichung
28 Feb 2007
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch
Uneingeschränkter Zugang

Anti-breast cancer activity of some novel quinoline derivatives

Online veröffentlicht: 30 Sep 2015
Volumen & Heft: Volumen 65 (2015) - Heft 3 (September 2015)
Seitenbereich: 271 - 283
Akzeptiert: 01 Jul 2015
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1846-9558
Erstveröffentlichung
28 Feb 2007
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch

1. S. Levy and S. J. Azoulay, Story about the origin of quinquina and quinidine, J. Cardiovasc. Electrophysiol.5 (1994) 635–636; DOI: 10.1111/j.1540-8167.1994.tb01304.x.10.1111/j.1540-8167.1994.tb01304.xSearch in Google Scholar

2. K. F. Wenckcbach, Cinchona derivatives in the treatment of heart disorders, JAMA81 (1923) 472–474; DOI: 10.1001/jama.1923.02650060042012.10.1001/jama.1923.02650060042012Search in Google Scholar

3. A. B. Adnan, A. E. Ola, A. Elsayed and J. I. Young Park, Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents, Eur. J. Med. Chem. 39 (2004) 249–255; DOI: 10.1016/j.ejmech.2003.12.-005.Search in Google Scholar

4. E. Sumesh, V. A. Airody and N. S. Suchetha, Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1, 2, 4-triazole moiety, Eur. J. Med. Chem. 44 (11) (2009) 4637–4647; DOI: 10.1016/j.ejmech.2009.06.031.10.1016/j.ejmech.2009.06.031Search in Google Scholar

5. M. Zhongze, H. Yoshio, N. Taro and C. Yingjie, Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities, Bioorg. Med. Chem. Lett.14 (2004) 1193–1196; DOI: 10.1016/j.bmcl.2003.12.048.10.1016/j.bmcl.2003.12.048Search in Google Scholar

6. E. Sumesh, V. A. Airody and R. A. Kumar, New 1,3-oxazolo [4,5-c] quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis properties, Eur. J. Med. Chem.45 (2010) 957–966; DOI: 10.1016/j.ejmech.2009.11.036.10.1016/j.ejmech.2009.11.036Search in Google Scholar

7. M. Hranjec, M. Kralj, I. Piantanida, M. Sedic, L. Šuman, K. Pavelic and G. Karminski-Zamola, Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a] quinolines. Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation, part 3, J. Med. Chem. 50 (2007) 5696–5711; DOI: 10.1021/jm070876h.10.1021/jm070876hSearch in Google Scholar

8. S. Madapa, Z. Tusi and S. Batra, Advances in the syntheses of quinoline and quinoline-annulated ring systems, Curr. Org. Chem.12 (2008) 1116–1183; DOI: 10.2174/138527208785740300.10.2174/138527208785740300Search in Google Scholar

9. P. Muthumani, S. Venkataraman, R. Meera, N. Govind, N. Chidambaranathan P. Devi and B. Kameswari, Synthesis and biological screening of some novel quinoline derivatives, Pharma Chem. 2 (2010) 385–396.Search in Google Scholar

10. J. Borran, A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione and C. T. Supuran, Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?, Bioorg. Med. Chem.7 (1999) 2397–2406; DOI: 10.1016/S0968-0896(99)00190-X.10.1016/S0968-0896(99)00190-XSearch in Google Scholar

11. V. K. Aqrawal, S. Bano, C. T. Supuran and P. V. Khadikar, QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents, Eur. J. Med. Chem. 39 (2004) 593–600; DOI: 10.1016/j.ejmech.2004.03.002.10.1016/j.ejmech.2004.03.00215236839Search in Google Scholar

12. W. Peczynska-Czoch, F. Pognan, L. Kaczmarek and J. Boratynski, Synthesis and structure-activity relationship of methyl-substituted indolo [2,3-b]quinolines: Novel cytotoxic, DNA topoisomerase II inhibitors, J. Med. Chem. 37 (1994) 3503–3510; DOI: 10.1021/jm-00047a008.Search in Google Scholar

13. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid, Y. M. Nissan and A. B. Ahmed, Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety, Eur. J. Med. Chem. 69 (2013) 373–383; DOI: 10.1016/j.ejmech.-2013.08.048.Search in Google Scholar

14. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660–670; DOI: 10.1007/s12272-013-00946.Search in Google Scholar

15. M. M. Ghorab, Z. H. Ismail, A. A. Radwan and M. Abdalla, Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety, Acta. Pharm.63 (2013) 1–18; DOI: 10.2478/acph-2013-0006.10.2478/acph-2013-000623482309Search in Google Scholar

16. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid and Y. M. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50–58; DOI: 10.10-02/chin.201328146.10.1248/cpb.c12-0081223302586Search in Google Scholar

17. D. A. Abou El Ella, M. M. Ghorab, H. I. Heiba and A. M. Soliman, Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents, Med. Chem. Res.21 (2012) 2395–2407; DOI: 10.1007/s00044-011-9751-9.10.1007/s00044-011-9751-9Search in Google Scholar

18. M. M. Ghorab, M. S. Alsaid and Y. M. Nissan, Dapson in heterocyclic chemistry, part VI: Synthesis and molecular docking of some novel sulfonebiscompounds of expected anticancer activity, Arzneimittel-forsch.62 (2012) 497–507; DOI: 10.1055/s-0032-1323660.10.1055/s-0032-132366023023519Search in Google Scholar

19. M. M. Ghorab, M. A. Shaaban, H. M. Refaat, H. I. Heiba and S. S. Ibrahim, Anticancer and radio-sensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety, Eur. J. Med. Chem. 53 (2012) 403–407; DOI: 10.1016/j.-ejmech.2012.04.009.Search in Google Scholar

20. M. M. Ghorab, F. A. Ragab, H. I. Heiba, Y. M. Nissan and W. M. Ghorab, Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of gamma-radiation, Arch. Pharm. Res. 8 (2012) 1335–1346; DOI: 10.1007/s-12272-012-0803-6.Search in Google Scholar

21. M. M. Ghorab, M. S. Alsaid and Y. M. Nissan, Dapson in heterocyclic chemistry, part V: Synthesis, molecular docking and anticancer activity of some novel sulfonylbis-compounds carrying biologically active dihydropyridine, dihydroisoquinoline, 1,3-dithiolan, 1,3-dithian, acrylamide, pyrazole, pyrazolopyrimidine and benzochromene moieties, Chem. Pharm. Bull.60 (2012) 1019–1028; DOI: org/10.-1248/cpb.c12-00292.Search in Google Scholar

22. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer. Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/-82.13.1107.Search in Google Scholar

23. M. M. Ghorab, M. S. Alsaid, H. A. Ghabour and H. K. Fun, Synthesis, crystal structure and anti-tumor activity of novel 2-cyano-N-(quinolin-3-yl) acetamide, Asian. J. Chem.26 (2014) 7389–7392; DOI: 10.14233/ajchem.17050.Search in Google Scholar

24. Y. Ogata and M. Tsuchida, Kinetics and mechanism of the Perkin reaction, J. Org. Chem.24 (1959) 78–83; DOI: 10.1021/jo01083a023.10.1021/jo01083a023Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo